ofa vs fda semaglutide The weight loss drug shortage is over — and some patients are 'panicking' Semaglutide vs Ozempic for Weight

According to the National Institutes of Health (NIH- department of the HHS), there is concern for acute pancreatitis and long-term consequences on the thyroid gland with usage of the GLP-1 RA medication

However, the potential for direct brain delivery through the olfactory pathway could provide unique appetite suppression benefits not achievable with injection alone

However, Orforglipron is an oral GLP-1 currently in development for the treatment of type 2 diabetes and obesity

That means patients with obesity can't just rely on changing their lifestyle to get better they need treatments to address the life-threatening consequences of their disease

Decision tree: Starting dose 0.25 to 0.5 mg weekly: use 2 mL bacteriostatic water (2.5 mg/mL)